Autosomal Recessive Familial Adenomatous Polyposis Treatment Market Size: An In-depth Study
As of 2024, the global Autosomal Recessive Familial Adenomatous Polyposis (AR-FAP) Treatment Market is valued at around USD 185.3 million. The market is expected to witness robust growth, with projections estimating its expansion to USD 780.6 million by 2037. This trajectory reflects a compound annual CAGR is 11.9% over the forecast period. The upward trend in market size can be attributed to increasing diagnosis rates, improved genetic testing availability, and the advent of innovative therapeutic interventions targeting AR-FAP’s genetic and clinical manifestations.